| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |